表紙
市場調查報告書

胰臟癌治療藥的全球市場

Pancreatic Cancer Drugs

出版商 Global Industry Analysts, Inc. 商品編碼 912756
出版日期 內容資訊 英文 244 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
胰臟癌治療藥的全球市場 Pancreatic Cancer Drugs
出版日期: 2019年10月01日內容資訊: 英文 244 Pages
簡介

本報告提供全球胰臟癌治療藥市場概要,彙整趨勢·發展的影響因素分析,競爭企業與市場佔有率,世界及地區·各主要國家的市場規模的變化與預測,主要企業簡介等資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 全球市場的企業佔有率
    • 全球胰臟癌治療藥市場上企業佔有率方案
  • 主要企業
  • 市場趨勢與發展因素
  • 全球市場預測

第3章 市場分析

  • 各地區市場分析
    • 美國
    • 加拿大
    • 日本
    • 中國
    • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 西班牙
    • 俄羅斯
    • 其他歐洲
    • 亞太地區
    • 澳洲
    • 印度
    • 韓國
    • 其他亞太地區
    • 南美
    • 阿根廷
    • 巴西
    • 墨西哥
    • 其他南美國家
    • 中東
    • 伊朗
    • 以色列
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 其他中東
    • 非洲

第4章 競爭企業

  • AMGEN
  • CELGENE CORPORATION
  • CLOVIS ONCOLOGY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • PFIZER
  • PHARMACYTE BIOTECH INC.
  • TEVA PHARMACEUTICAL INDUSTRIES

第5章 調查資料

目錄
Product Code: MCP-6317

Pancreatic Cancer Drugs market worldwide is projected to grow by US$1.4 Billion, driven by a compounded growth of 7.7%. Endocrine, one of the segments analyzed and sized in this study, displays the potential to grow at over 7.4%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$1.4 Billion by the year 2025, Endocrine will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 6.6% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$49.7 Million to the region's size and clout in the next 5 to 6 years. Over US$43.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Endocrine will reach a market size of US$64.3 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 11.3% over the next couple of years and add approximately US$396.8 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, Amgen, Inc.; Celgene Corporation; Clovis Oncology; Eli Lilly and Company; F. Hoffmann-La Roche AG; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; PharmaCyte Biotech, Inc.; Teva Pharmaceutical Industries Ltd.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Pancreatic Cancer Drugs Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Pancreatic Cancer Drugs Global Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
  • TABLE 2: Pancreatic Cancer Drugs Global Retrospective Market Scenario in US$ Million by Region/Country: 2009-2017
  • TABLE 3: Pancreatic Cancer Drugs Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Endocrine (Type) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 5: Endocrine (Type) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 6: Endocrine (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Exocrine (Type) Potential Growth Markets Worldwide in US$ Million: 2018 to 2025
  • TABLE 8: Exocrine (Type) Historic Market Perspective by Region/Country in US$ Million: 2009 to 2017
  • TABLE 9: Exocrine (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Biologic (Therapy) Geographic Market Spread Worldwide in US$ Million: 2018 to 2025
  • TABLE 11: Biologic (Therapy) Region Wise Breakdown of Global Historic Demand in US$ Million: 2009 to 2017
  • TABLE 12: Biologic (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Chemotherapy (Therapy) World Market Estimates and Forecasts by Region/Country in US$ Million: 2018 to 2025
  • TABLE 14: Chemotherapy (Therapy) Market Historic Review by Region/Country in US$ Million: 2009 to 2017
  • TABLE 15: Chemotherapy (Therapy) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Other Therapies (Therapy) World Market by Region/Country in US$ Million: 2018 to 2025
  • TABLE 17: Other Therapies (Therapy) Historic Market Analysis by Region/Country in US$ Million: 2009 to 2017
  • TABLE 18: Other Therapies (Therapy) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Pancreatic Cancer Drugs Market Share (in %) by Company: 2019 & 2025
    • TABLE 19: United States Pancreatic Cancer Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 20: Pancreatic Cancer Drugs Market in the United States by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 21: United States Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 22: United States Pancreatic Cancer Drugs Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
    • TABLE 23: Pancreatic Cancer Drugs Market in the United States by Therapy: A Historic Review in US$ Million for 2009-2017
    • TABLE 24: United States Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 25: Canadian Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 26: Canadian Pancreatic Cancer Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 27: Pancreatic Cancer Drugs Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 28: Canadian Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
    • TABLE 29: Canadian Pancreatic Cancer Drugs Historic Market Review by Therapy in US$ Million: 2009-2017
    • TABLE 30: Pancreatic Cancer Drugs Market in Canada: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • JAPAN
    • TABLE 31: Japanese Market for Pancreatic Cancer Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 32: Pancreatic Cancer Drugs Market in Japan: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 33: Japanese Pancreatic Cancer Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 34: Japanese Market for Pancreatic Cancer Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
    • TABLE 35: Pancreatic Cancer Drugs Market in Japan: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
    • TABLE 36: Japanese Pancreatic Cancer Drugs Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 37: Chinese Pancreatic Cancer Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 38: Pancreatic Cancer Drugs Historic Market Analysis in China in US$ Million by Type: 2009-2017
    • TABLE 39: Chinese Pancreatic Cancer Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 40: Chinese Pancreatic Cancer Drugs Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
    • TABLE 41: Pancreatic Cancer Drugs Historic Market Analysis in China in US$ Million by Therapy: 2009-2017
    • TABLE 42: Chinese Pancreatic Cancer Drugs Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Pancreatic Cancer Drugs Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 43: European Pancreatic Cancer Drugs Market Demand Scenario in US$ Million by Region/Country: 2018-2025
    • TABLE 44: Pancreatic Cancer Drugs Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 45: European Pancreatic Cancer Drugs Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 46: European Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 47: Pancreatic Cancer Drugs Market in Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 48: European Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 49: European Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
    • TABLE 50: Pancreatic Cancer Drugs Market in Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 51: European Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 52: Pancreatic Cancer Drugs Market in France by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 53: French Pancreatic Cancer Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 54: French Pancreatic Cancer Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 55: Pancreatic Cancer Drugs Market in France by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 56: French Pancreatic Cancer Drugs Historic Market Scenario in US$ Million by Therapy: 2009-2017
    • TABLE 57: French Pancreatic Cancer Drugs Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 58: Pancreatic Cancer Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 59: German Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 60: German Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 61: Pancreatic Cancer Drugs Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 62: German Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 63: German Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 64: Italian Pancreatic Cancer Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 65: Pancreatic Cancer Drugs Historic Market Analysis in Italy in US$ Million by Type: 2009-2017
    • TABLE 66: Italian Pancreatic Cancer Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 67: Italian Pancreatic Cancer Drugs Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
    • TABLE 68: Pancreatic Cancer Drugs Historic Market Analysis in Italy in US$ Million by Therapy: 2009-2017
    • TABLE 69: Italian Pancreatic Cancer Drugs Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 70: United Kingdom Market for Pancreatic Cancer Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 71: Pancreatic Cancer Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 72: United Kingdom Pancreatic Cancer Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 73: United Kingdom Market for Pancreatic Cancer Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
    • TABLE 74: Pancreatic Cancer Drugs Market in the United Kingdom: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
    • TABLE 75: United Kingdom Pancreatic Cancer Drugs Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 76: Spanish Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 77: Spanish Pancreatic Cancer Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 78: Pancreatic Cancer Drugs Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 79: Spanish Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
    • TABLE 80: Spanish Pancreatic Cancer Drugs Historic Market Review by Therapy in US$ Million: 2009-2017
    • TABLE 81: Pancreatic Cancer Drugs Market in Spain: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 82: Russian Pancreatic Cancer Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 83: Pancreatic Cancer Drugs Market in Russia by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 84: Russian Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 85: Russian Pancreatic Cancer Drugs Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
    • TABLE 86: Pancreatic Cancer Drugs Market in Russia by Therapy: A Historic Review in US$ Million for 2009-2017
    • TABLE 87: Russian Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 88: Rest of Europe Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 89: Pancreatic Cancer Drugs Market in Rest of Europe in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 90: Rest of Europe Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 91: Rest of Europe Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
    • TABLE 92: Pancreatic Cancer Drugs Market in Rest of Europe in US$ Million by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 93: Rest of Europe Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 94: Asia-Pacific Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 95: Pancreatic Cancer Drugs Market in Asia-Pacific: Historic Market Analysis in US$ Million by Region/Country for the Period 2009-2017
    • TABLE 96: Asia-Pacific Pancreatic Cancer Drugs Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 97: Pancreatic Cancer Drugs Market in Asia-Pacific by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 98: Asia-Pacific Pancreatic Cancer Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 99: Asia-Pacific Pancreatic Cancer Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 100: Pancreatic Cancer Drugs Market in Asia-Pacific by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 101: Asia-Pacific Pancreatic Cancer Drugs Historic Market Scenario in US$ Million by Therapy: 2009-2017
    • TABLE 102: Asia-Pacific Pancreatic Cancer Drugs Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 103: Pancreatic Cancer Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 104: Australian Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 105: Australian Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 106: Pancreatic Cancer Drugs Market in Australia: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 107: Australian Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 108: Australian Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 109: Indian Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 110: Indian Pancreatic Cancer Drugs Historic Market Review by Type in US$ Million: 2009-2017
    • TABLE 111: Pancreatic Cancer Drugs Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 112: Indian Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
    • TABLE 113: Indian Pancreatic Cancer Drugs Historic Market Review by Therapy in US$ Million: 2009-2017
    • TABLE 114: Pancreatic Cancer Drugs Market in India: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 115: Pancreatic Cancer Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 116: South Korean Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 117: Pancreatic Cancer Drugs Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
    • TABLE 118: Pancreatic Cancer Drugs Market in South Korea: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 119: South Korean Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 120: Pancreatic Cancer Drugs Market Share Distribution in South Korea by Therapy: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 121: Rest of Asia-Pacific Market for Pancreatic Cancer Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 122: Pancreatic Cancer Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 123: Rest of Asia-Pacific Pancreatic Cancer Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 124: Rest of Asia-Pacific Market for Pancreatic Cancer Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
    • TABLE 125: Pancreatic Cancer Drugs Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
    • TABLE 126: Rest of Asia-Pacific Pancreatic Cancer Drugs Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 127: Latin American Pancreatic Cancer Drugs Market Trends by Region/Country in US$ Million: 2018-2025
    • TABLE 128: Pancreatic Cancer Drugs Market in Latin America in US$ Million by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 129: Latin American Pancreatic Cancer Drugs Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 130: Latin American Pancreatic Cancer Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 131: Pancreatic Cancer Drugs Historic Market Analysis in Latin America in US$ Million by Type: 2009-2017
    • TABLE 132: Latin American Pancreatic Cancer Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 133: Latin American Pancreatic Cancer Drugs Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
    • TABLE 134: Pancreatic Cancer Drugs Historic Market Analysis in Latin America in US$ Million by Therapy: 2009-2017
    • TABLE 135: Latin American Pancreatic Cancer Drugs Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 136: Argentinean Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 137: Pancreatic Cancer Drugs Market in Argentina in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 138: Argentinean Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 139: Argentinean Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
    • TABLE 140: Pancreatic Cancer Drugs Market in Argentina in US$ Million by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 141: Argentinean Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 142: Pancreatic Cancer Drugs Market in Brazil by Type: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 143: Brazilian Pancreatic Cancer Drugs Historic Market Scenario in US$ Million by Type: 2009-2017
    • TABLE 144: Brazilian Pancreatic Cancer Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 145: Pancreatic Cancer Drugs Market in Brazil by Therapy: Estimates and Projections in US$ Million for the Period 2018-2025
    • TABLE 146: Brazilian Pancreatic Cancer Drugs Historic Market Scenario in US$ Million by Therapy: 2009-2017
    • TABLE 147: Brazilian Pancreatic Cancer Drugs Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 148: Pancreatic Cancer Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 149: Mexican Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 150: Mexican Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 151: Pancreatic Cancer Drugs Market in Mexico: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 152: Mexican Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 153: Mexican Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 154: Rest of Latin America Pancreatic Cancer Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 155: Pancreatic Cancer Drugs Market in Rest of Latin America by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 156: Rest of Latin America Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 157: Rest of Latin America Pancreatic Cancer Drugs Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
    • TABLE 158: Pancreatic Cancer Drugs Market in Rest of Latin America by Therapy: A Historic Review in US$ Million for 2009-2017
    • TABLE 159: Rest of Latin America Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 160: The Middle East Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Region/Country: 2018-2025
    • TABLE 161: Pancreatic Cancer Drugs Market in the Middle East by Region/Country in US$ Million: 2009-2017
    • TABLE 162: The Middle East Pancreatic Cancer Drugs Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 163: The Middle East Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Type: 2018 to 2025
    • TABLE 164: The Middle East Pancreatic Cancer Drugs Historic Market by Type in US$ Million: 2009-2017
    • TABLE 165: Pancreatic Cancer Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 166: The Middle East Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Therapy: 2018 to 2025
    • TABLE 167: The Middle East Pancreatic Cancer Drugs Historic Market by Therapy in US$ Million: 2009-2017
    • TABLE 168: Pancreatic Cancer Drugs Market in the Middle East: Percentage Share Breakdown of Sales by Therapy for 2009, 2019, and 2025
  • IRAN
    • TABLE 169: Iranian Market for Pancreatic Cancer Drugs: Annual Sales Estimates and Projections in US$ Million by Type for the Period 2018-2025
    • TABLE 170: Pancreatic Cancer Drugs Market in Iran: Historic Sales Analysis in US$ Million by Type for the Period 2009-2017
    • TABLE 171: Iranian Pancreatic Cancer Drugs Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 172: Iranian Market for Pancreatic Cancer Drugs: Annual Sales Estimates and Projections in US$ Million by Therapy for the Period 2018-2025
    • TABLE 173: Pancreatic Cancer Drugs Market in Iran: Historic Sales Analysis in US$ Million by Therapy for the Period 2009-2017
    • TABLE 174: Iranian Pancreatic Cancer Drugs Market Share Analysis by Therapy: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 175: Israeli Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Type: 2018-2025
    • TABLE 176: Pancreatic Cancer Drugs Market in Israel in US$ Million by Type: A Historic Review for the Period 2009-2017
    • TABLE 177: Israeli Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 178: Israeli Pancreatic Cancer Drugs Market Estimates and Forecasts in US$ Million by Therapy: 2018-2025
    • TABLE 179: Pancreatic Cancer Drugs Market in Israel in US$ Million by Therapy: A Historic Review for the Period 2009-2017
    • TABLE 180: Israeli Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 181: Saudi Arabian Pancreatic Cancer Drugs Market Growth Prospects in US$ Million by Type for the Period 2018-2025
    • TABLE 182: Pancreatic Cancer Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Type: 2009-2017
    • TABLE 183: Saudi Arabian Pancreatic Cancer Drugs Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 184: Saudi Arabian Pancreatic Cancer Drugs Market Growth Prospects in US$ Million by Therapy for the Period 2018-2025
    • TABLE 185: Pancreatic Cancer Drugs Historic Market Analysis in Saudi Arabia in US$ Million by Therapy: 2009-2017
    • TABLE 186: Saudi Arabian Pancreatic Cancer Drugs Market by Therapy: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 187: Pancreatic Cancer Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 188: United Arab Emirates Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 189: Pancreatic Cancer Drugs Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
    • TABLE 190: Pancreatic Cancer Drugs Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 191: United Arab Emirates Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 192: Pancreatic Cancer Drugs Market Share Distribution in United Arab Emirates by Therapy: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 193: Pancreatic Cancer Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Type for the Period 2018-2025
    • TABLE 194: Rest of Middle East Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Type: 2009-2017
    • TABLE 195: Rest of Middle East Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 196: Pancreatic Cancer Drugs Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Million by Therapy for the Period 2018-2025
    • TABLE 197: Rest of Middle East Pancreatic Cancer Drugs Historic Market Analysis in US$ Million by Therapy: 2009-2017
    • TABLE 198: Rest of Middle East Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 199: African Pancreatic Cancer Drugs Market Estimates and Projections in US$ Million by Type: 2018 to 2025
    • TABLE 200: Pancreatic Cancer Drugs Market in Africa by Type: A Historic Review in US$ Million for 2009-2017
    • TABLE 201: African Pancreatic Cancer Drugs Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 202: African Pancreatic Cancer Drugs Market Estimates and Projections in US$ Million by Therapy: 2018 to 2025
    • TABLE 203: Pancreatic Cancer Drugs Market in Africa by Therapy: A Historic Review in US$ Million for 2009-2017
    • TABLE 204: African Pancreatic Cancer Drugs Market Share Breakdown by Therapy: 2009 VS 2019 VS 2025

IV. COMPETITION

  • AMGEN
  • CELGENE CORPORATION
  • CLOVIS ONCOLOGY
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • MERCK & CO., INC.
  • NOVARTIS INTERNATIONAL AG
  • PFIZER
  • PHARMACYTE BIOTECH INC.
  • TEVA PHARMACEUTICAL INDUSTRIES

V. CURATED RESEARCH

Back to Top